Cerebrolysin

Cerebrolysin peptide complexFPE-507

A neurotrophic peptide complex studied for cognition and brain recovery.

Research use onlyCognitive

RouteInjection

Molecular weight

Mixture of peptides (~10 kDa)

Residues

Mixture (low-molecular-weight peptides)

Half-life

Variable (multi-peptide preparation)

Typical form

Injectable (IM/IV), ampoules

Status

Research use only

Overview

Cerebrolysin is a peptide preparation derived from porcine brain tissue, containing neurotrophic factors and amino acids. It is widely used in Europe, Russia, and Asia for stroke recovery, cognitive decline, and brain injury. Among nootropic users it is one of the most discussed injectable compounds.

Dosing

Injection

Starting dose: 5 mL
Common dose: 5–10 mL
Frequency: 1× daily
Notes: 5 mL ampoules; common 10–20 day courses.

Reported research/reference doses for educational purposes only. Always verify against primary literature and applicable regulations. Not medical advice.

How it works

Cerebrolysin mimics the action of endogenous neurotrophic factors such as BDNF and NGF. It supports neuronal survival, synaptic plasticity, neurogenesis, and blood-brain barrier integrity, and has been studied for neuroprotection after stroke and traumatic brain injury.

Common research uses

Cognitive recovery after stroke or injury
Neuroprotection and neurogenesis research
Memory and learning support
Neurodegenerative disease studies

Considerations

Prescription medication in many countries; sourced from porcine brain tissue. Injection-site reactions are possible. Quality and legality vary by region, so verify local regulations.